Literature DB >> 8546029

Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.

T Hirose1, B W Scheithauer, M B Lopes, H A Gerber, H J Altermatt, M J Hukee, S R VandenBerg, J C Charlesworth.   

Abstract

The cellular nature of the giant eosinophilic cells of tuber and of the cells comprising subependymal giant cell astrocytoma (SEGA) in tuberous sclerosis (TS) remains unclear. To assess the characteristics of these lesions, 13 tubers and 6 SEGA were immunohistochemically studied with glial and neuron-associated antigens. In addition to conventional ultrastructure, 6 tubers and 8 SEGA were subjected to immunoelectron microscopic study for glial fibrillary acidic protein (GFAP) and somatostatin. Eosinophilic giant cells of tubers were positive for vimentin (100%), GFAP (77%) and S-100 protein (92%); such cells were also found to a various extent to be reactive for neuron-associated antigens, including neurofilament (NF) proteins (38%) or class III beta-tubulin (77%). SEGA also showed variable immunoreactivity for GFAP (50%) or for S-100 protein (100%); NF epitopes, class III beta-tubulin, and calbindin 28-kD were expressed in 2 (33%), 5 (83%) and 4 (67%) cases, respectively. Cytoplasmic staining for somatostatin (50%), met-enkephalin (50%), 5-hydroxytryptamine (33%), beta-endorphin (33%) and neuropeptide Y (17%) was noted in SEGA, but not in tubers. Ultrastructurally, the giant cells of tubers and the cells of SEGA contained numerous intermediate filaments, frequent lysosomes and occasional rectangular or rhomboid membrane-bound crystalloids exhibiting lamellar periodicity and structural transition to lysosomes. Some SEGA cells showed features suggestive of neuronal differentiation, including stacks of rough endoplasmic reticulum, occasional microtubules and a few dense-core granules. Furthermore, in one case of tuber, a process of a single large cell was seen to be engaged in synapse formation. Intermediate filaments within a few cells of both lesions were decorated by gold particle-labeled GFAP antiserum. Within the tumor cells of SEGA, irregular, non-membrane-bound, electron-lucent areas often contained somatostatin-immunoreactive particles, whereas the latter could not be detected in tuber. The present study provides further evidence of divergent glioneuronal differentiation, both in the giant cells of tubers and the cells of SEGA. The findings of similar cells at different sites, including the subependymal zone, white matter ("heterotopias"), and cortex indirectly supports the idea that these lesions of TS result from a migration abnormality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546029     DOI: 10.1007/bf00315012

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  44 in total

Review 1.  International tuberous sclerosis conference.

Authors:  E S Roach
Journal:  J Child Neurol       Date:  1990-10       Impact factor: 1.987

2.  A comparative study on genetic heterogeneity in tuberous sclerosis: evidence for one gene on 9q34 and a second gene on 11q22-23.

Authors:  L A Janssen; S Povey; J Attwood; L A Sandkuyl; D Lindhout; P Flodman; M Smith; J R Sampson; J L Haines; E C Merkens
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Tuberous sclerosis: a Golgi study of cortical tuber.

Authors:  I Ferrer; I Fabregues; J Coll; T Ribalta; A Rives
Journal:  Clin Neuropathol       Date:  1984 Mar-Apr       Impact factor: 1.368

5.  Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study.

Authors:  J M Bonnin; L J Rubinstein; S C Papasozomenos; P J Marangos
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Subependymal giant cell tumor of tuberose sclerosis. A light and ultrastructural study.

Authors:  J P de Chadarévian; R D Hollenberg
Journal:  J Neuropathol Exp Neurol       Date:  1979-07       Impact factor: 3.685

7.  Crystalline inclusions in a subependymal giant cell tumor in a patient with tuberous sclerosis.

Authors:  V Jay; V Edwards; J T Rutka
Journal:  Ultrastruct Pathol       Date:  1993 Sep-Oct       Impact factor: 1.094

8.  Subependymal giant-cell tumor: astrocytic or neuronal?

Authors:  Y Nakamura; L E Becker
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

Review 9.  Tuberous sclerosis.

Authors:  D J Kwiatkowski; M P Short
Journal:  Arch Dermatol       Date:  1994-03

10.  Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry on the CNS.

Authors:  T M Chou; S M Chou
Journal:  Clin Neuropathol       Date:  1989 Jan-Feb       Impact factor: 1.368

View more
  30 in total

1.  MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex.

Authors:  Anne Gallagher; Ellen P Grant; Neel Madan; Delma Y Jarrett; David A Lyczkowski; Elizabeth A Thiele
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

Review 2.  Neurological manifestations of tuberous sclerosis complex.

Authors:  P Curatolo
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

3.  Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.

Authors:  G Rennebeck; E V Kleymenova; R Anderson; R S Yeung; K Artzt; C L Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 4.  Intermediate filaments in the nervous system: implications in cancer.

Authors:  C L Ho; R K Liem
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

5.  Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.

Authors:  Carlos Cepeda; Véronique M André; Jason S Hauptman; Irene Yamazaki; My N Huynh; Julia W Chang; Jane Y Chen; Robin S Fisher; Harry V Vinters; Michael S Levine; Gary W Mathern
Journal:  Neurobiol Dis       Date:  2011-08-23       Impact factor: 5.996

Review 6.  Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Authors:  Y Rajesh; Ipsita Pal; Payel Banik; Sandipan Chakraborty; Sachin A Borkar; Goutam Dey; Ahona Mukherjee; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

7.  Tuberous sclerosis: differences between cerebral and cerebellar cortical tubers in a pediatric population.

Authors:  L Martí-Bonmatí; F Menor; R Dosdá
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

Review 8.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

9.  Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.

Authors:  Heon You; Young Im Kim; Soo Young Im; Haeyoung Suh-Kim; Sun Ha Paek; Sung-Hye Park; Dong Gyu Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

10.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Authors:  Sharon W Way; James McKenna; Ulrike Mietzsch; R Michelle Reith; Henry Cheng-Ju Wu; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.